Literature DB >> 1467297

A case of Sweet's syndrome and myelodysplasia: response to cyclosporin.

G R Sharpe1, H M Leggat.   

Abstract

A case of severe Sweet's syndrome associated with myelodysplasia is reported. The skin lesions responded to high doses of systemic steroids, but recurred rapidly on dose reduction. Treatment with a low dose of cyclosporin resulted in sustained clearance of the skin lesions, and was associated with a stable haemoglobin level, without the need for further blood transfusions.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1467297     DOI: 10.1111/j.1365-2133.1992.tb14856.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  5 in total

1.  Sweet syndrome secondary to inflammatory bowel disease.

Authors:  Malcolm M Wells; William Stecho; Bret Wehrli; Nitin Khanna
Journal:  Can J Gastroenterol       Date:  2013-03       Impact factor: 3.522

Review 2.  Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders.

Authors:  Diana Faulds; Karen L Goa; Paul Benfield
Journal:  Drugs       Date:  1993-06       Impact factor: 9.546

3.  Acute febrile neutrophilic dermatosis associated with JAK-2 positive myeloproliferative disorder.

Authors:  Dean Smyth; Jey Selwyn
Journal:  BMJ Case Rep       Date:  2016-04-26

Review 4.  Insights Into the Pathogenesis of Sweet's Syndrome.

Authors:  Michael S Heath; Alex G Ortega-Loayza
Journal:  Front Immunol       Date:  2019-03-12       Impact factor: 7.561

Review 5.  Sweet's syndrome--a comprehensive review of an acute febrile neutrophilic dermatosis.

Authors:  Philip R Cohen
Journal:  Orphanet J Rare Dis       Date:  2007-07-26       Impact factor: 4.123

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.